These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 15851751)

  • 1. Cerebrotendinous xanthomatosis: a treatable ataxia.
    Clemen CS; Spottke EA; Lütjohann D; Urbach H; von Bergmann K; Klockgether T; Dodel R
    Neurology; 2005 Apr; 64(8):1476. PubMed ID: 15851751
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical reasoning: a case of treatable spastic paraparesis.
    McKinnon JH; Bosch EP
    Neurology; 2012 Aug; 79(6):e50-3. PubMed ID: 22869688
    [No Abstract]   [Full Text] [Related]  

  • 3. Normalisation of serum cholestanol concentration in a patient with cerebrotendinous xanthomatosis by combined treatment with chenodeoxycholic acid, simvastatin and LDL apheresis.
    Dotti MT; Lütjohann D; von Bergmann K; Federico A
    Neurol Sci; 2004 Oct; 25(4):185-91. PubMed ID: 15549503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cerebrotendinous xanthomatosis].
    Burghaus L; Liu W; Haupt WF
    Dtsch Med Wochenschr; 2007 Jul; 132(27):1463-6. PubMed ID: 17583829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrotendinous xanthomatosis in three siblings from a Chinese family.
    Ko KF; Lee KW
    Singapore Med J; 2001 Jan; 42(1):30-2. PubMed ID: 11361235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrotendinous xanthomatosis: a rare cause of spinocerebellar syndrome.
    Ostrowska M; Banaszkiewicz K; Kiławiec A; Róg T; Lütjohann D; Szczudlik A
    Neurol Neurochir Pol; 2011; 45(6):600-603. PubMed ID: 22212991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrotendinous xanthomatosis: a treatable cause of metabolic ataxia.
    Mukherjee AA; Chawla BP; Rathi SS; Puthran RS
    J Assoc Physicians India; 2007 Sep; 55():655-7. PubMed ID: 18051740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cerebrotendinous xanthomatosis: utility of nuclear magnetic resonance image in the follow-up and response to treatment].
    Cuende E; Gómez-Rz de Mendarozqueta M; Vesga JC; Saracíbar N; Ibáñez-Avilés A; Castellano-Hurtado C
    Rev Neurol; 1996 Dec; 24(136):1535-8. PubMed ID: 9064170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A neurological rarity not to be missed: cerebrotendinous xanthomatosis.
    Rafiq M; Sharrack N; Shaw PJ; Hadjivassiliou M
    Pract Neurol; 2011 Oct; 11(5):296-300. PubMed ID: 21921005
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cerebrotendinous xanthomatosis--a treatable metabolic disorder].
    Sperhake JP; Matschke J
    Nervenarzt; 2004 Jun; 75(6):608. PubMed ID: 15257383
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cerebrotendinous xanthomatosis, a treatable metabolic disorder].
    Heller R; Grau AJ; Schäbitz WR; Schwaninger M
    Nervenarzt; 2002 Dec; 73(12):1160-6. PubMed ID: 12486565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Laboratory diagnosis of a rare congenital neurodegenerative disease: cerebrotendinous xanthomatosis].
    Varga VE; Katkó M; Harangi J; Balogh I; Kapás I; Madar L; Seres I; Molnár MJ; Paragh G; Kovács GG; Harangi M
    Orv Hetil; 2014 May; 155(21):811-6. PubMed ID: 24836315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic diarrhea and juvenile cataracts: think cerebrotendinous xanthomatosis and treat.
    Berginer VM; Gross B; Morad K; Kfir N; Morkos S; Aaref S; Falik-Zaccai TC
    Pediatrics; 2009 Jan; 123(1):143-7. PubMed ID: 19117873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Could steroids mask the diagnosis of cerebrotendinous xanthomatosis?
    Siman-Tov T; Meiner V; Gadoth N
    J Neurol Sci; 2006 Apr; 243(1-2):83-6. PubMed ID: 16445943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and molecular genetic features of cerebrotendinous xanthomatosis patients in Chinese families.
    Chen C; Zhang Y; Wu H; Sun YM; Cai YH; Wu JJ; Wang J; Gong LY; Ding ZT
    Metab Brain Dis; 2017 Oct; 32(5):1609-1618. PubMed ID: 28623566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrotendinous xanthomatosis: a treatable neurodegenerative disease.
    Sandeep P; Jayakrishnan C; Sadanan S; Sreekumar S; Thulasidharan NK
    J Assoc Physicians India; 2009 Oct; 57():716-7. PubMed ID: 20329433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrotendinous xanthomatosis: the effectiveness of high-dose piracetam for the treatment of cerebellar and sensorial ataxia.
    Uygunoglu U; Gunduz A; Menku SF; Yilmaz B; Hatipoglu E; Yalcinkaya C; Saip S; Apaydin H
    Cerebellum; 2014 Dec; 13(6):787-90. PubMed ID: 25084753
    [No Abstract]   [Full Text] [Related]  

  • 18. The wide spectrum of cerebrotendinous xanthomatosis: Case report of a rare but treatable disease.
    Rosafio F; Cavallieri F; Guaraldi P; Taroni F; Nichelli PF; Mandrioli J
    Clin Neurol Neurosurg; 2016 Apr; 143():1-3. PubMed ID: 26874936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cerebrotendinous xanthomatosis is a rare disorder, which requires a specific treatment].
    Blaabjerg M; Marjanovic D
    Ugeskr Laeger; 2013 Jan; 175(5):285-6. PubMed ID: 23369332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cerebrotendinous xanthomatosis without tendinous xanthomas: presentation of two cases].
    Campdelacreu J; Muñoz E; Cervera A; Jaumà S; Girós M; Tolosa E
    Neurologia; 2002 Dec; 17(10):647-50. PubMed ID: 12487962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.